Recent reports indicate that when it comes to pharmaceutical and biopharmaceutical products and their active ingredients, counterfeiting continues to be a challenging problem. According to the USTR’s (United States Trade Representative) 2017 report published this month (Special 301 Report), last year about 90% of the counterfeit pharmaceuticals seized in the U.S. originated from China, Singapore, and India. Overall, this accounts …
How Pharmacies And Pharma Could Work Hand-In-Hand
Pharmaceutical companies should take note as pharmacies are becoming more and more a “one-stop” shop for the health and wellness needs of patients, according to a recent McCann Health white paper. The research focuses on the fact that, as pharmacies become the preferred choice for patients’ healthcare needs, pharmaceutical companies should realize that pharmacists are healthcare professionals who are highly …
REA JET To Exhibit At Forest Products Machinery And Equipment Expo
It’s May, and June is just weeks away. REA JET is proud to announce we will be exhibiting our industrial coding solutions at the Forest Products Machinery and Equipment Expo in Atlanta June 14-16! Who typically attends this event? Whether your field is engineered wood, lumber manufacturing, forestry/biomass, or treating and paper; company owners, managers, those in sales, and engineering …
Pharma Coders – 31% 1st Quarter Profit For GSK Due To Lung, HIV Drugs
A recent Bloomberg article revealed the U.K. drug maker GlaxoSmithKline posted a first quarter profit gain of 31%, an increase that is likely due to rising sales of lung drugs and HIV treatments in conjunction with a weaker pound. Just weeks ago, Emma Walmsley took over as CEO at GSK. These reports are likely to boost her efforts in working …
PMMI Study Reveals Hurdles In Pharma Serialization Implementation
A recent article at Healthcare Packaging claims that findings in the 2016 PMMI Pharmaceutical & Medical Devices: Trends and Opportunities in Packaging Operations survey indicate that the entire healthcare industry will be impacted by serialization implementation and compliance deadlines. Serialization and aggregation are expected to drive a transition for all drug makers. The survey points out the biggest barriers to …